Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Earnings Call: MindWalk meldet 54 % Umsatzwachstum für Q2 2025 (Investing.com DE) +++ MINDWALK Aktie -4,27%

MINDWALK Aktie

 >MINDWALK Aktienkurs 
1.57 EUR    +3.3%    (Tradegate)
Ask: 1.63 EUR / 3100 Stück
Bid: 1.6 EUR / 3200 Stück
Tagesumsatz: 4074 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
MINDWALK Aktie über LYNX handeln
>MINDWALK Performance
1 Woche: -12,1%
1 Monat: -1,9%
3 Monate: 0%
6 Monate: 0%
1 Jahr: 0%
laufendes Jahr: 0%
>MINDWALK Aktie
Name:  MINDWALK HOLDINGS CORP.
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA6026871054 / A41GYL
Symbol/ Ticker:  TQB0 (Frankfurt) / HYFT (NASDAQ)
Kürzel:  FRA:TQB0, ETR:TQB0, TQB0:GR, NASDAQ:HYFT
Index:  -
Webseite:  https://www.mindwalkai.co..
Profil:  MindWalk Holdings Corp. is a pioneering bio-native..
>Volltext..
Marktkapitalisierung:  73.52 Mio. EUR
Unternehmenswert:  72.78 Mio. EUR
Umsatz:  13.65 Mio. EUR
EBITDA:  -4.35 Mio. EUR
Nettogewinn:  -17.63 Mio. EUR
Gewinn je Aktie:  -0.52 EUR
Schulden:  2.29 Mio. EUR
Liquide Mittel:  3.02 Mio. EUR
Operativer Cashflow:  -5.32 Mio. EUR
Bargeldquote:  0.29
Umsatzwachstum:  -14.28%
Gewinnwachstum:  3.42%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  MINDWALK
Letzte Datenerhebung:  15.12.25
>MINDWALK Kennzahlen
Aktien/ Unternehmen:
Aktien: 46.16 Mio. St.
Frei handelbar: 86.9%
Leerverk. Aktien: -
Rückkaufquote: -9.55%
Mitarbeiter: 102
Umsatz/Mitarb.: 0.15 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 117.2%
Bewertung:
KGV: -
KGV lG: -
KUV: 5.47
KBV: 5.48
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: 50.69%
Gewinnmarge: -134.23%
Operative Marge: -52.78%
Managementeffizenz:
Gesamtkaprendite: -59.43%
Eigenkaprendite: -110.94%
>MINDWALK Peer Group

Es sind 182 Aktien bekannt.
 
15.12.25 - 18:06
Earnings Call: MindWalk meldet 54 % Umsatzwachstum für Q2 2025 (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
15.12.25 - 17:30
MindWalk Holdings Corp. (HYFT) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
 
MindWalk Holdings Corp. (HYFT) delivered earnings and revenue surprises of -400.00% and -25.68%, respectively, for the quarter ended October 2025. Do the numbers hold clues to what lies ahead for the stock?...
15.12.25 - 14:36
MindWalk GAAP EPS of -C$0.07, revenue of C$4.12M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
15.12.25 - 14:36
MindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline (Business Wire)
 
VICTORIA, British Columbia--(BUSINESS WIRE)--$HYFT #ai--MindWalk (NASDAQ: HYFT), a BioNative AI biotherapeutic research and technology company combining in silico and wet lab operations for biologics discovery and development, today announced financial results for the second quarter of fiscal 2026 and provided updates on its AI driven asset pipeline and strategic initiatives. MindWalk operates a proprietary BioNative AI platform built on patented HYFT® patterns—evolution shaped subsequence codes that link sequence, structure and function. These patterns underpin LensAI™, a software platform that harmonizes and analyzes diverse biological data to deliver actionable insights. Financial Highlights (Quarter Ended October 31, 2025) Revenue: $4.1 million, up 54% year-over-year and 30% sequentially, driven by improved project revenue and better utilization across both project-based and platform-related revenue streams. Gross margin: 65%, up from 51% in the prior year quarter. Gross profit increased signific...
15.12.25 - 11:12
Stock Market Today: Dow Futures, S&P 500 Advance Ahead Of Key Economic Data: iRobot, Argenx, MindWalk In Focus (Benzinga)
 
U.S. stock futures are up early Monday morning, following a mixed week that saw rotation out of expensive tech stocks in favor of value. read more...
08.12.25 - 14:33
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2026 on December 15, 2025 (Business Wire)
 
The Company to host an earnings conference call via webcast AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced that it will host a conference call to discuss its quarterly results and recent business highlights for second quarter fiscal year 2026, on Monday, December 15, 2025, at 10:30 am Eastern Time. The financial results will be issued in a press release prior to the call. MindWalk management will host the conference call followed by a question-and-answer period. Conference Call and Webcast Details The Company will host a live conference call and webcast to discuss these results and provide a corporate update on Monday, December 15, 2025, at 10:30AM ET. The conference call will be webcast live and available for replay via a link provided in the Events section of the Company's IR pages at: https://ir.mindwalkai.com/events-and-presentations/default.aspx Participant Dial-...
21.10.25 - 14:30
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy (Business Wire)
 
AUSTIN, Texas--(BUSINESS WIRE)--$HYFT #AI--MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), bio-native AI company today announces the appointment of industry veteran R. Scott Areglado as Chief Financial Officer (CFO), effective October 20, 2025. “Scott's extensive experience leading financial strategy for high-growth, publicly traded healthcare and technology companies makes him an ideal addition to our executive team,” said Dr. Jennifer Bath, MindWalk CEO. “His proven ability to strengthen financial systems, execute disciplined growth initiatives, and communicate effectively with the investment community will be instrumental as we scale our Bio-Native AI platform globally.” Mr. Areglado brings more than 25 years of financial leadership experience across the healthcare, life sciences, and technology sectors, including extensive expertise in corporate finance, strategic planning, capital markets, and investor relations for publicly traded companies. ...
15.10.25 - 13:03
MindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial Expansion (Business Wire)
 
AUSTIN, Texas--(BUSINESS WIRE)--$HYFT #AI--MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), a Bio-Native AI company today announced the appointment of industry veteran Thomas W. Lynch, Ph.D. as Chief Business Officer (CBO), effective October 20, 2025. “Tom's combination of biotech depth and software commercialization expertise directly supports MindWalk's next path of growth,” said Dr. Jennifer Bath CEO of MindWalk. “As we expand the reach of our HYFT-powered Deep Data platform across pharma and biotech markets worldwide, Tom's leadership in scaling global teams and forging strategic partnerships will be instrumental in creating long-term shareholder value.” Dr. Lynch is an accomplished industry leader with over two decades of experience focused at the intersection of biotechnology and software innovation. Dr. Lynch has a strong track record in scaling global commercial organizations, launching high-impact products, and driving market adoption of ...
09.10.25 - 13:48
MindWalk Holdings announces 2.3M share buyback program (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
09.10.25 - 13:03
MindWalk Announces Share Repurchase Program (Business Wire)
 
AUSTIN, Texas--(BUSINESS WIRE)--$hyft #AI--MindWalk Holdings Corp. (“MindWalk” or the “Company”) (NASDAQ: “HYFT”), a bio-native AI company, today announced that to underscore its confidence in MindWalk's future development and growth prospects, its Board of Directors (the “Board”) has authorized a share repurchase program under which MindWalk may repurchase up to 2.3 million common shares of the Company, no par value (the “Common Shares”) over the twelve-month period commencing on October 15th, 2025, and ending no later than October 15th, 2026 (the “Program”). This represents approximately 5% of the 46,154,188 Common Shares currently issued and outstanding. CEO Jennifer Bath stated, “With our balance sheet significantly strengthened and our business moving toward stronger financial health, we believe it is appropriate to add a share repurchase program to our long-term capital allocation toolkit. There have been periods where the market price of our stock has disconnected materia...
05.09.25 - 16:57
XFRA: ISIN Change (XETRA)
 
Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen CA38150N1078 Goldshore Resources Inc. 05.09.2025 CA38076G1037 Gold x2 Mining Inc. 08.09.2025 Tausch 1:1 US78418A6047 Safe & Green Holdings Corp. 05.09.2025 US78418A7037 Safe & Green Holdings Corp. 08.09.2025 Tausch 64:1 CA45257F2008 MindWalk Holdings Corp. 05.09.2025 CA6026871054 MindWalk Holdings Corp. 08.09.2025 Tausch 1:1 US8549361017 Stardust Power Inc. 05.09.2025 US8549362007 Stardust Power Inc. 08.09.2025 Tausch 10:1 US6915431026 Oxford Lane Capital Corp. 05.09.2025 US6915438476 Oxford Lane Capital Corp. 08.09.2025 Tausch 5:1...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Gott lebt in der Musik. - Sprichwort Indien
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!